Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (30)
Lei Wang & Jin-lin Peng. (2023) Association of hypoxia-inducible factor 1α expression with susceptibility to hepatitis B virus-related hepatocellular carcinoma: A meta-analysis. The International Journal of Biological Markers 38:3-4, pages 149-158.
Crossref
Crossref
Dayong Zheng, Jun Li, Han Yan, Gang Zhang, Wei Li, Edward Chu & Ning Wei. (2023) Emerging roles of Aurora-A kinase in cancer therapy resistance. Acta Pharmaceutica Sinica B 13:7, pages 2826-2843.
Crossref
Crossref
Roberta Cacioppo & Catherine Lindon. (2022) Regulating the regulator: a survey of mechanisms from transcription to translation controlling expression of mammalian cell cycle kinase Aurora A. Open Biology 12:9.
Crossref
Crossref
Karuna Mittal, Jaspreet Kaur, Shaligram Sharma, Nivya Sharma, Guanhao Wei, Ishita Choudhary, Precious Imhansi-Jacob, Nagini Maganti, Shrikant Pawar, Padmashree Rida, Michael S. Toss, Mohammed Aleskandarany, Emiel A. Janssen, Håvard Søiland, Meenakshi. V. Gupta, Michelle D. Reid, Emad A. Rakha & Ritu Aneja. (2022) Hypoxia Drives Centrosome Amplification in Cancer Cells via HIF1α-dependent Induction of Polo-Like Kinase 4. Molecular Cancer Research 20:4, pages 596-606.
Crossref
Crossref
Nidhi Varshney, Annu Rani, Dharmendra Kashyap, Deeksha Tiwari & Hem Chandra Jha. 2022. Protein Kinase Inhibitors. Protein Kinase Inhibitors
261
322
.
Salini Das, Elizabeth Mahapatra, Souvick Biswas, Madhumita Roy & Sutapa Mukherjee. (2021) Emerging Role of Aurora A in Radioresistance: A Comprehensive Review. EMJ Oncology, pages 81-90.
Crossref
Crossref
Carolina Méndez-Blanco, Paula Fernández-Palanca, Flavia Fondevila, Javier González-Gallego & José L. Mauriz. (2021) Prognostic and clinicopathological significance of hypoxia-inducible factors 1α and 2α in hepatocellular carcinoma: a systematic review with meta-analysis. Therapeutic Advances in Medical Oncology 13, pages 175883592098707.
Crossref
Crossref
Lei Fan, Xiang Huang, Jing Chen, Kai Zhang, Yan-hong Gu, Jing Sun & Shi-yun Cui. (2020) Long Noncoding RNA MALAT1 Contributes to Sorafenib Resistance by Targeting miR-140-5p/Aurora-A Signaling in Hepatocellular Carcinoma. Molecular Cancer Therapeutics 19:5, pages 1197-1209.
Crossref
Crossref
Soo Mi Ki, Ji Hyun Kim, So Yeon Won, Shin Ji Oh, In Young Lee, Young‐Ki Bae, Ki Wha Chung, Byung‐Ok Choi, Boyoun Park, Eui‐Ju Choi & Ji Eun Lee. (2019)
CEP
41‐mediated ciliary tubulin glutamylation drives angiogenesis through
AURKA
‐dependent deciliation
. EMBO reports 21:2.
Crossref
Crossref
Ze-Tian Shen, Ying Chen, Gui-Chun Huang, Xi-Xu Zhu, Rui Wang & Long-Bang Chen. (2019) Aurora-a confers radioresistance in human hepatocellular carcinoma by activating NF-κB signaling pathway. BMC Cancer 19:1.
Crossref
Crossref
Linxin Teng, Kaiyuan Wang, Yu Liu, Yanxia Ma, Weiping Chen & Lei Bi. (2019) Based on Integrated Bioinformatics Analysis Identification of Biomarkers in Hepatocellular Carcinoma Patients from Different Regions. BioMed Research International 2019, pages 1-17.
Crossref
Crossref
Delowar Hossain & William Y. Tsang. (2019) The role of ubiquitination in the regulation of primary cilia assembly and disassembly. Seminars in Cell & Developmental Biology 93, pages 145-152.
Crossref
Crossref
Li‐yun Yang, Ya‐min Shan, Yi Zhang, En‐hui Zhou, Xiao‐ping Chen & Hao Zhang. (2019) Aurora kinase A induces chemotherapy resistance through revival of dormant cells in laryngeal squamous cell carcinoma. Head & Neck 41:7, pages 2239-2248.
Crossref
Crossref
Benelita T. Elie, Jacob Fernández-Gallardo, Natalia Curado, Mike A. Cornejo, Joe W. Ramos & María Contel. (2019) Bimetallic titanocene-gold phosphane complexes inhibit invasion, metastasis, and angiogenesis-associated signaling molecules in renal cancer. European Journal of Medicinal Chemistry 161, pages 310-322.
Crossref
Crossref
Kai Zhang, Ting Wang, Hao Zhou, Bing Feng, Ying Chen, Yingru Zhi & Rui Wang. (2018) A Novel Aurora-A Inhibitor (MLN8237) Synergistically Enhances the Antitumor Activity of Sorafenib in Hepatocellular Carcinoma. Molecular Therapy - Nucleic Acids 13, pages 176-188.
Crossref
Crossref
Manman Deng, Yuanfei Shi, Kai Chen, Haijun Zhao, Yan Wang, Siting Xie, Jintao Zhao, Yiming Luo, Zhihong Fang, Yaqun Fan & Bing Xu. (2018) CS2164 exerts an antitumor effect against human Non-Hodgkin's lymphomas in vitro and in vivo. Experimental Cell Research 369:2, pages 356-362.
Crossref
Crossref
Wang Liu, Yu Lu, Xiaoping Chai, Xiao Liu, Tong Zhu, Xihan Wu, Yanfen Fang, Xuan Liu & Xiongwen Zhang. (2016) Antitumor activity of TY-011 against gastric cancer by inhibiting Aurora A, Aurora B and VEGFR2 kinases. Journal of Experimental & Clinical Cancer Research 35:1.
Crossref
Crossref
Shiyun Cui, Kai Zhang, Chen Li, Jing Chen, Yan Pan, Bing Feng, Lei Lu, Ziman Zhu, Rui Wang & Longbang Chen. (2016) Methylation-associated silencing of microRNA-129-3p promotes epithelial-mesenchymal transition, invasion and metastasis of hepatocelluar cancer by targeting Aurora-A. Oncotarget 7:47, pages 78009-78028.
Crossref
Crossref
Min Yan, Chunli Wang, Bin He, Mengying Yang, Mengying Tong, Zijie Long, Bing Liu, Fei Peng, Lingzhi Xu, Yan Zhang, Dapeng Liang, Haixin Lei, Sen Subrata, Keith W. Kelley, Eric W.-F. Lam, Bilian Jin & Quentin Liu. (2016) Aurora-A Kinase: A Potent Oncogene and Target for Cancer Therapy. Medicinal Research Reviews 36:6, pages 1036-1079.
Crossref
Crossref
Donghern Kim, Jin Dai, Youn-hee Park, Leonard Yenwong Fai, Lei Wang, Poyil Pratheeshkumar, Young-Ok Son, Kazuya Kondo, Mei Xu, Jia Luo, Xianglin Shi & Zhuo Zhang. (2016) Activation of Epidermal Growth Factor Receptor/p38/Hypoxia-inducible Factor-1α Is Pivotal for Angiogenesis and Tumorigenesis of Malignantly Transformed Cells Induced by Hexavalent Chromium. Journal of Biological Chemistry 291:31, pages 16271-16281.
Crossref
Crossref
Ahmed Katsha, Abbes Belkhiri, Laura Goff & Wael El-Rifai. (2015) Aurora kinase A in gastrointestinal cancers: time to target. Molecular Cancer 14:1.
Crossref
Crossref
Yunseon Jang, Jeongsu Han, Soo Jeong Kim, Jungim Kim, Min Joung Lee, Soyeon Jeong, Min Jeong Ryu, Kang-Sik Seo, Song-Yi Choi, Minho Shong, Kyu Lim, Jun Young Heo & Gi Ryang Kweon. (2015) Suppression of mitochondrial respiration with auraptene inhibits the progression of renal cell carcinoma: involvement of HIF-1α degradation. Oncotarget 6:35, pages 38127-38138.
Crossref
Crossref
Keisuke Nakao, Shinji Tanaka, Tomoya Miura, Kota Sato, Satoshi Matsumura, Arihiro Aihara, Yusuke Mitsunori, Daisuke Ban, Takanori Ochiai, Atsushi Kudo, Shigeki Arii & Minoru Tanabe. (2015) Novel Aurora/vascular endothelial growth factor receptor dual kinase inhibitor as treatment for hepatocellular carcinoma. Cancer Science 106:8, pages 1016-1022.
Crossref
Crossref
Carolina Simioni, Alice Cani, Alberto M. Martelli, Giorgio Zauli, Ayman A.M. Alameen, Simona Ultimo, Giovanna Tabellini, James A. McCubrey, Silvano Capitani & Luca M. Neri. (2015) The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells. Oncotarget 6:19, pages 17147-17160.
Crossref
Crossref
Ruhee Dere, Ashley Lyn Perkins, Tasneem Bawa-Khalfe, Darius Jonasch & Cheryl Lyn Walker. (2015) β-Catenin Links von Hippel-Lindau to Aurora Kinase A and Loss of Primary Cilia in Renal Cell Carcinoma. Journal of the American Society of Nephrology 26:3, pages 553-564.
Crossref
Crossref
Kai Zhang, Jing Chen, Dongqin Chen, Jiayuan Huang, Bing Feng, Siqi Han, Yitian Chen, Haizhu Song, Wei De, Ziman Zhu, Rui Wang & Longbang Chen. (2014) Aurora-A promotes chemoresistance in hepatocelluar carcinoma by targeting NF-kappaB/microRNA-21/PTEN signaling pathway. Oncotarget 5:24, pages 12916-12935.
Crossref
Crossref
Robin P.F. Dullaart, Nasser M. Al-Daghri, Messoud Ashina, Alberto Bouzas-Mosquera, Natale Daniele Brunetti, Christa Buechler, Harn-Shen Chen, Juan J. Corrales, Massimo D'Archivio, Alessandra Dei Cas, Guadalupe Garcia Pino, Segundo A. Gómez-Abril, Dávid Győri, Helmuth Haslacher, Christian Herder, Michiel N. Kerstens, Michael Koutsilieris, Carlo Lombardi, Graziana Lupattelli, Attila Mócsai, Pavlos Msaouel, Alberto Orfao, Paulina Ormazabal, Richard Pacher, Thomas Perkmann, Jesús Peteiro, Max Plischke, Niki L. Reynaert, Maria Anastasia Ricci, Nicolás Roberto Robles, Milagros Rocha, Erica P.A. Rutten, Shaun Sabico, Francesca Santamaria, Francesco Santoro, Andreas Schmid, Morten Schmidt, Henrik Winther Schytz, Kou-Gi Shyu, Hayato Tada, Barbara Thorand, Giuliana Valerio, David L. Vesely, Tzu-En Wu, Masakazu Yamagishi & Yao-Tsung Yeh. (2014) Research update for articles published in EJCI in 2012. European Journal of Clinical Investigation 44:10, pages 1010-1023.
Crossref
Crossref
Jie Chen, Qu Lin, Jing-Yun Wen, Xing Li, Xiao-Kun Ma, Xin-Juan Fan, Qin-Hua Cao, Min Dong, Li Wei, Zhan-Hong Chen, Xiao-Yun Li, Tian-Tian Wang, Quentin Liu, Xiang-Bo Wan, Yan-Fang Xing & Xiang-Yuan Wu. (2014) Prognosis value of mitotic kinase Aurora-A for primary duodenal adenocarcinoma. Tumor Biology 35:9, pages 9361-9370.
Crossref
Crossref
Zhenhai Yu, Yingying Ge, Lei Xie, Teng Zhang, Liangqian Huang, Xiaoping Zhao, Jianjun Liu & Gang Huang. (2014) Using a yeast two-hybrid system to identify FTCD as a new regulator for HIF-1α in HepG2 cells. Cellular Signalling 26:7, pages 1560-1566.
Crossref
Crossref
Heng Xiao, Rongliang Tong, Shaobing Cheng, Zhen Lv, Chaofeng Ding, Chengli Du, Haiyang Xie, Lin Zhou, Jian Wu & Shusen Zheng. (2014)
BAG3 and HIF-1
α
Coexpression Detected by Immunohistochemistry Correlated with Prognosis in Hepatocellular Carcinoma after Liver Transplantation
. BioMed Research International 2014, pages 1-9.
Crossref
Crossref